Modern medicine evolution is driving the growth in Global Optical genome mapping Market in the forecast period, 2022-2026.
Bio-pharmaceutical advances for the latest drug development and genome manipulation for enhancement of other treatment methods and instruments is driving the growth of the global optical genome mapping market in the upcoming five years. Moreover, increased advancement in the biotechnological methods, and bioinformatic processes is further aiding the growth of the market in the next five years. Additionally, advancing methods of healthcare, medicine research, biotech evolution along with technological advancement for various kind of diagnostic tests are further substantiating the growth of the global optical genome mapping market in the future five years of forecast until 2026.
Optical genome mapping is a biotechnical procedure of constructing ordered, genome-wide, high-resolution restriction maps from single, stained molecules of DNA, called optical maps. The complete procedure involves a complex process of DNA barcoding, template nicking, gap formation, fluorochrome incorporation, imaging, and photo bleaching along with repeated cycle of fluorochrome incorporation and photo bleaching. The process is less time consuming and is less costly as compared to similar usability biotechnological processes.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "Global Optical genome mapping Market"
https://www.techsciresearch.com/report/optical-genome-mapping-market/7731.html
The global optical genome mapping market segmentation is based on component, application, end user, competitional landscape, and regional distribution. Based on application, the market is further bifurcated into genome assembly, SV detection, microbial strain typing, haplotype phasing, and others. Genome assembly is an application of optical genome mapping in the field of bioinformatics, where the computational process of resolving the sequence composition of the genetic material (DNA) within the cell of an organism. SV detection or structural variation analysis are genomic alteration that involves larger DNA segments often more than 1 Kb, (Kilobase). Advancing biotechnological advances for the healthcare evolution is driving the growth of the global optical genome mapping in the next five years.
Based on component, the market is further divided between instruments and consumables. Optical genome mapping plays major part in drug development procedures thus, consumable component can be expected to hold the largest revenue shares of the market segment and assert its dominance over the segment in the upcoming five years. Diagnostic prenatal testing for the detection and prevention of genetic disorders optical genome mapping is a novel method is able to detect all classes of structural variations (SVs), including copy number variations (CNVs) and thus provide better testing instruments and testing kits.
The market is expected to support significant growth in the upcoming five years. For example, Irys Instrument reveals genome structure by performing low-cost next-generation mapping at single-molecule resolution. Irys provides the long-range genomic information required for high-quality de novo assembly and high-resolution discovery of structural variations. These next-generation mapping tools along with next-generation sequencing, can be used especially for building reference genomes.
Holding the major shares of the global optical genome mapping market are OpGen, Inc., Bionano Genomics, Inc., Nabsys Inc, Nucleome Informatics Pvt Ltd, France Génomique, among others. Market players are actively involved in the research and technological development in the product developments. The advanced technology has made it possible for the industry to provide excellent services through optical genome mapping. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7731
Customers can also request for 10% free customization on this report.
“North America is anticipated to be the most volatile and most promising market in the future five years. High prevalence of optical genome mapping instruments and related products and their surging demand is anticipated to aid the growth of the market in the upcoming five years. Also, the region consists of the United States and Canada likewise major economies that support excellent research and biotechnological studies for various purposes and the presence of multiple market players that hold major shares of the market are other major factors that is expected to support the growth of the market too. Consistent research and technological advancement may support the new market players trying to enter the market in the future five years and in their brand establishment,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.
“Global Optical Genome Mapping Market By Component (Instruments v/s Consumables) By Application (Genome Assembly, SV Detection, Microbial Strain Typing, Haplotype Phasing, Others) By End User (Biotechnology & Pharmaceutical Companies, Research & Academic Institutions, Clinical Laboratories, Others) By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of global optical genome mapping and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global optical genome mapping market.
Browse Related Reports:
Global Neuroendocrine Tumor Market By Therapy Type (Chemotherapy, Immunotherapy, Hormonal Therapy, Surgery, Targeted Therapy, Others) By Mechanism of Action (Somatostatin Analogs, Tyrosine Kinase Inhibitor, Peptide receptor radionuclide, Alfa-interferon, Proton pump inhibitors, Others) By Drug Type (Everolimus, Sunitib malate, Lorlatinib, Nivolumab, Bevacizumab, Others) By Indication (Gastrointestinal NET, Lung NET, Pancreatic NET, Appendiceal NET, Others) By Route of Administration (Oral, Parenteral, Others) By End User (Hospitals, Ambulatory Surgical Centers, Oncology Centers, Others (GI centers, Cardio-thoracic centers, NET centers) By Region, Competition Forecast & Opportunities, 2026
https://www.techsciresearch.com/report/neuroendocrine-tumor-market/7606.html
Global Nanopore Sequencing Market By Product (Consumables v/s Instruments), By Nucleotide Sequenced (DNA v/s RNA), By Type (Direct Current Sequencing, Synthetic DNA and Horizontal Tunnelling Current Sequencing, Optical Reading Techniques Sequencing, Exonuclease Sequencing), By Type of Nanopore (Solid State, Biological, Hybrid), By Application (Human Genetics, Clinical Research, Plant Research, Microbiology, Animal Research), By End User (Biotechnology Companies, Clinical Laboratories, Academic & Research Institutes), By Region, Competition Forecast & Opportunities, 2026
https://www.techsciresearch.com/report/nanopore-sequencing-market/7677.html
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com/
For More Market Research Blogs Visit: https://techsciblog.com/
No comments:
Post a Comment